1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Biologics Safety Testing Market, by Test Type
6.1. Introduction
6.2. Adventitious Agent Detection Tests
6.3. Bioburden Tests
6.4. Cell Line Authentication and Characterization Tests
6.5. Endotoxin Tests
6.6. Residual Host Contaminant Detection Tests
6.7. Sterility Tests

7. Biologics Safety Testing Market, by Application
7.1. Introduction
7.2. Blood and Blood-Related Products Testing
7.3. Cellular and Gene Therapy
7.4. Stem Cell Research
7.5. Tissue and Tissue-Related Products Testing
7.6. Vaccine & Therapeutics Development

8. California Biologics Safety Testing Market

9. Florida Biologics Safety Testing Market

10. Illinois Biologics Safety Testing Market

11. New York Biologics Safety Testing Market

12. Ohio Biologics Safety Testing Market

13. Pennsylvania Biologics Safety Testing Market

14. Texas Biologics Safety Testing Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Avance Biosciences Inc.
16.2. Charles River Laboratories International, Inc.
16.3. Cytovance Biologics, Inc.
16.4. Eurofins Scientific Se
16.5. Lonza Group Ltd.
16.6. Merck KGaA
16.7. Pace Analytical Services Inc.
16.8. Sartorius AG
16.9. Source Bioscience
16.10. Thermo Fisher Scientific Inc.
16.11. Toxikon Corporation
16.12. Wuxi Apptec

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2026
FIGURE 7. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 20. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2026
FIGURE 22. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 33. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 34. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BIOLOGICS SAFETY TESTING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: SCORES
TABLE 18. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: BUSINESS STRATEGY
TABLE 19. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: PRODUCT SATISFACTION
TABLE 20. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: RANKING
TABLE 21. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 22. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: MERGER & ACQUISITION
TABLE 23. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 24. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 25. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: INVESTMENT & FUNDING
TABLE 26. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 27. UNITED STATES BIOLOGICS SAFETY TESTING MARKET: LICENSE & PRICING

Companies Mentioned

Avance Biosciences Inc.
Charles River Laboratories International, Inc.
Cytovance Biologics, Inc.
Eurofins Scientific Se
Lonza Group Ltd.
Merck KGaA
Pace Analytical Services Inc.
Sartorius AG
Source Bioscience
Thermo Fisher Scientific Inc.
Toxikon Corporation
Wuxi Apptec